The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...

The health secretary's stance on vaccines mirrors a broader decline in public support for childhood immunizations. A 2024 Gallup poll shows 40 percent of Americans say it's extremely important for ...

Frank DeStefano, MD, MPH, was there when the CDC's Vaccine Safety Datalink (VSD) first came online in 1990, when the agency ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the ...

Top U.S. vaccine regulator Vinay Prasad and FDA Commissioner Marty Makary, both of whom have been critical of U.S. COVID ...

Fear of babies contracting the contagious and potentially deadly virus has spurred the surge in vaccinations amid Texas’ ...

The McKinney-Vento Act lets students without guardians or documents enroll immediately. Officials say they followed the law ...

The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...

"Again, I don't want to give advice," Kennedy said. "I can tell you, in Europe, they don't use the chickenpox vaccine ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.